Prism Ideas, a provider of medical communications and drug development consultancy services, is to open its first North American office in Boston, Massachusetts. The new office will enable the company to expand its clinical consultancy services, support existing clients based in the US and facilitate the delivery of new therapies to market faster.
The company’s US expansion comes at a time of sustained growth for Prism, which also has offices in the UK and Switzerland. ‘The US is the most important market for the pharmaceutical industry,’ comments Dr James Sawyer, ceo at Prism Ideas. ‘Greater opportunity for face-to-face interaction with many of our clients will enable us to enhance our partnerships while new opportunities will ensure that we can successfully continue our strategy for growth.’
Explaining the importance of this strategic move, non-executive chairman Nigel Brooksby said: ‘Prism’s growth is being driven by the need for pharmaceutical companies to effectively manage every step of their development and marketing processes, and to have a partner who can provide the expertise to help meet the stringent legislation enforced by regulatory bodies. With the company’s new office in Boston, we anticipate being to able to grow our business and work more closely with clients to offer pragmatic solutions and ensure the successful delivery of new therapies to the marketplace.’
